ALPS Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $826K | Sell |
|
|||||
|
2025
Q2 | $729K | Sell |
|
|||||
|
2025
Q1 | $906K | Sell |
|
|||||
|
2024
Q4 | $1.36M | Buy |
|
|||||
|
2024
Q3 | $1.72M | Sell |
|
|||||
|
2024
Q2 | $1.9M | Buy |
|
|||||
|
2024
Q1 | $1.91M | Buy |
|
|||||
|
2023
Q4 | $1.49M | Buy |
|
|||||
|
2023
Q3 | $959K | Buy |
|
|||||
|
2023
Q2 | $1.18M | Buy |
|
|||||
|
2023
Q1 | $1.12M | Sell |
|
|||||
|
2022
Q4 | $1.42M | Buy |
|
|||||
|
2022
Q3 | $718K | Sell |
|
|||||
|
2022
Q2 | $748K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.48M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $380K | Buy |
|
|||||
|
2016
Q4 | $344K | Sell |
|
|||||
|
2016
Q3 | $518K | Sell |
|
|||||
|
2016
Q2 | $609K | Buy |
|
|||||
|
2016
Q1 | $420K | Sell |
|
|||||
|
2015
Q4 | $2.04M | Sell |
|
|||||
|
2015
Q3 | $16.2K | Buy |
|
|||||
|
2015
Q2 | $2.46M | Buy |
|
|||||
|
2015
Q1 | $1.34M | Buy |
|